Eco R1 Capital, LLC Arcus Biosciences, Inc. Transaction History

Eco R1 Capital, LLC

$2.31 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$17.23 - $37.73 $56.3 Million - $123 Million	-3,265,101 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$28.92 - $41.83 $65.3 Million - $94.5 Million	-2,258,257 Reduced 40.89%	3,265,101 $103 Million
Q4 2021 Feb 14, 2022	BUY	$31.38 - $48.47 $12.6 Million - $19.4 Million	400,999 Added 7.83%	5,523,358 $224 Million
Q3 2021 Nov 15, 2021	BUY	$26.93 - $37.68 $48.1 Million - $67.3 Million	1,787,112 Added 53.58%	5,122,359 $179 Million
Q2 2021 Aug 16, 2021	BUY	$22.75 - $35.77 $25.9 Million - $40.8 Million	1,139,355 Added 51.89%	3,335,247 $91.6 Million
Q4 2020 Feb 16, 2021	BUY	$17.0 - $32.36 $6.56 Million - $12.5 Million	385,892 Added 21.32%	2,195,892 $57 Million
Q2 2020 Aug 14, 2020	BUY	$13.97 - $36.56 $21.2 Million - $55.5 Million	1,517,900 Added 519.65%	1,810,000 $44.8 Million
Q1 2020 May 15, 2020	SELL	$8.78 - $19.28 $3.84 Million - $8.44 Million	-437,805 Reduced 59.98%	292,100 $4.05 Million
Q4 2019 Feb 14, 2020	SELL	$7.33 - $10.79 $180,318 - $265,434	-24,600 Reduced 3.26%	729,905 $7.37 Million
Q3 2019 Nov 14, 2019	SELL	$6.44 - $10.18 $4.73 Million - $7.47 Million	-733,700 Reduced 49.3%	754,505 $6.87 Million
Q2 2019 Aug 14, 2019	BUY	$7.29 - $13.38 $3.63 Million - $6.66 Million	498,059 Added 50.3%	1,488,205 $11.8 Million
Q1 2019 May 15, 2019	SELL	$8.95 - $12.49 $2.09 Million - $2.91 Million	-233,349 Reduced 19.07%	990,146 $12.4 Million
Q4 2018 Feb 14, 2019	SELL	$9.74 - $14.5 $9.87 Million - $14.7 Million	-1,012,892 Reduced 45.29%	1,223,495 $13.2 Million
Q1 2018 May 15, 2018	BUY	$15.44 - $17.71 $34.5 Million - $39.6 Million	2,236,387 New	2,236,387 $34.5 Million

Others Institutions Holding RCUS

# of Institutions

195

Shares Held

51.7M

Call Options Held

236K

Put Options Held

141K

Black Rock Inc. New York, NY

9.76M
Shares

$129 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.47M
Shares

$72.2 Million
0.0% of portfolio
Woodline Partners LP San Francisco, CA

3.48M
Shares

$45.9 Million
0.48% of portfolio
State Street Corp Boston, MA

3.01M
Shares

$39.7 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

2.44M
Shares

$32.2 Million
0.1% of portfolio

View Full List

About Arcus Biosciences, Inc.

Ticker RCUS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,160,000
Market Cap $953M
Description
Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...

More about RCUS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Eco R1 Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eco R1 Capital, LLC with notifications on news.

Account